Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Induction TPF followed by IMRT +/- concurrent cisplatin in NPC
NCT02434614Phase 3Unknown
- Start
- Mar 2015
- Primary completion
- May 2021
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Cisplatin micelle injection (HA132) in nasopharyngeal carcinoma (NPC). Status: unknown.
02
Drugs
Cisplatin micelle injection (HA132)
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT02434614.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02434614.